AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2016
Feb 4, 2016
35124_dirs_2016-02-04_a4883087-9f34-4eb3-b726-0ac931a184fb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2016-02-02
Reporting Person: Braun Donald P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-02-02 | Celsion Corporation Common Stock | A | 5000 | $1.33 | Acquired | 5000 | Direct |
Footnotes
F1: The Filer was provided a fully vested stock grant on February 2, 2016.
F2: Represents the per share fair value of the common stock grant based on the closing price of Celsion Corporation Common Stock on the date of grant.
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23